D. Western Therapeutics Institute, Inc.
Status: Publicly traded
Direct answer
D. Western Therapeutics Institute, Inc. is publicly traded on JPX under the ticker 4576.T.
D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting...
Can you invest in D. Western Therapeutics Institute, Inc.?
Yes. D. Western Therapeutics Institute, Inc. trades publicly on JPX as 4576.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for D. Western Therapeutics Institute, Inc.
Detailed equity research is provided by MarketSnap.